[
  {
    "generic_name": "Flunitrazepam",
    "brand_names": ["Rohypnol", "Hypnodorm", "Flunipam"],
    "active_ingredients": "Flunitrazepam 1mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7830",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": false,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 14,
    "requires_photo_id": true,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Hypnotic/Sedative",
    "mechanism_of_action": "GABA-A receptor positive allosteric modulator with potent hypnotic effects",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Sleep patterns, Cognitive function, Dependence signs, Abuse indicators",
    "monitoring_frequency_days": 14,
    "addiction_risk": true,
    "abuse_potential": "severe",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Severe respiratory insufficiency", "Sleep apnea", "Myasthenia gravis", "Severe hepatic impairment"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": true,
    "black_box_warning_text": "Extremely high abuse potential, associated with drug-facilitated sexual assault, causes anterograde amnesia, severe withdrawal seizures, banned in many countries",
    "major_drug_interactions": ["Opioids (fatal respiratory depression)", "CNS depressants (severe sedation)", "Alcohol (severe CNS depression, amnesia)", "CYP3A4 inhibitors (increased levels)"],
    "food_interactions": "Avoid alcohol completely, grapefruit juice may increase levels",
    "search_keywords": ["flunitrazepam", "rohypnol", "roofies", "date rape drug", "hypnotic", "benzodiazepine"],
    "generic_variations": ["Flunitrazepam base"],
    "common_misspellings": ["Flunitrazapam", "Rohypnoll", "Flunitrzepam"],
    "safer_alternatives": ["Zolpidem (lower abuse potential)", "Zopiclone", "Melatonin", "CBT for insomnia"],
    "cheaper_alternatives": ["Diazepam", "Nitrazepam"],
    "notes": "Notorious for abuse in drug-facilitated crimes due to rapid onset, potent amnesia, and rapid dissolution. Banned in US and many countries. Strictly controlled in Nigeria. 10x more potent than diazepam. Causes severe anterograde amnesia. Very difficult to discontinue.",
    "is_active": true
  },
  {
    "generic_name": "Zolpidem",
    "brand_names": ["Ambien", "Stilnoct", "Zolfresh"],
    "active_ingredients": "Zolpidem Tartrate 10mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7831",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2015-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Not controlled (POM)",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 14,
    "requires_photo_id": false,
    "therapeutic_class": "Non-benzodiazepine Hypnotic (Z-drug)",
    "pharmacological_class": "Sedative-Hypnotic",
    "mechanism_of_action": "Selective GABA-A receptor agonist at alpha-1 subunit",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Sleep quality, Complex behaviors (sleepwalking, sleep-driving), Dependence signs",
    "monitoring_frequency_days": 14,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Severe hepatic impairment", "Respiratory depression", "Sleep apnea", "Myasthenia gravis"],
    "allergy_cross_reactions": ["Other Z-drugs (zopiclone, zaleplon)"],
    "black_box_warning": true,
    "black_box_warning_text": "Complex sleep behaviors including sleep-walking, sleep-driving, and other activities while not fully awake. Risk of serious injuries and death. Discontinue immediately if occurs.",
    "major_drug_interactions": ["CNS depressants (increased sedation)", "CYP3A4 inhibitors (increased levels)", "Alcohol (enhanced CNS effects)", "Opioids (respiratory depression)"],
    "food_interactions": "Avoid alcohol, do not take with or after meals (delays onset)",
    "search_keywords": ["zolpidem", "ambien", "z-drug", "insomnia", "sleep medication", "hypnotic"],
    "generic_variations": ["Zolpidem Tartrate", "Zolpidem Extended-Release"],
    "common_misspellings": ["Zolpidem", "Ambian", "Zolpedem"],
    "safer_alternatives": ["Melatonin", "Doxepin (low dose)", "CBT for insomnia", "Sleep hygiene"],
    "cheaper_alternatives": ["Doxepin", "Trazodone (off-label)"],
    "notes": "Non-benzodiazepine 'Z-drug' for short-term insomnia treatment. FDA black box warning for complex sleep behaviors. Reports of sleep-driving, sleep-eating, and other dangerous activities. Short half-life (2-3 hours). Take immediately before bed. Maximum 7-10 days continuous use recommended.",
    "is_active": true
  },
  {
    "generic_name": "Temazepam",
    "brand_names": ["Restoril", "Normison", "Temaze"],
    "active_ingredients": "Temazepam 15mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7832",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Hypnotic",
    "mechanism_of_action": "GABA-A receptor positive modulator",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Sleep quality, Daytime sedation, Dependence signs",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "X",
    "breastfeeding_safe": false,
    "major_contraindications": ["Pregnancy", "Sleep apnea", "Severe respiratory insufficiency", "Myasthenia gravis"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["CNS depressants (enhanced sedation)", "Opioids (respiratory depression)", "Alcohol (severe CNS depression)", "CYP3A4 inhibitors"],
    "food_interactions": "Avoid alcohol",
    "search_keywords": ["temazepam", "restoril", "insomnia", "benzodiazepine", "sleep medication"],
    "generic_variations": ["Temazepam base"],
    "common_misspellings": ["Temazapam", "Temazepem", "Restorill"],
    "safer_alternatives": ["Zolpidem", "Melatonin", "Doxepin", "CBT for insomnia"],
    "cheaper_alternatives": ["Diazepam (off-label for sleep)"],
    "notes": "Intermediate-acting benzodiazepine specifically for insomnia. Pregnancy category X (causes birth defects). Gel-filled capsules were commonly abused IV in 1980s-90s, leading to reformulation. Short-term use only (7-10 days). Taper slowly to discontinue.",
    "is_active": true
  },
  {
    "generic_name": "Oxazepam",
    "brand_names": ["Serax", "Serenid", "Alepam"],
    "active_ingredients": "Oxazepam 15mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7833",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Anxiolytic",
    "mechanism_of_action": "GABA-A receptor positive modulator",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Anxiety levels, Sedation, Liver function, Dependence",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "moderate",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Acute narrow-angle glaucoma", "Severe respiratory insufficiency", "Severe hepatic impairment"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["CNS depressants (sedation)", "Opioids (respiratory depression)", "Alcohol (CNS depression)"],
    "food_interactions": "Avoid alcohol",
    "search_keywords": ["oxazepam", "serax", "anxiety", "benzodiazepine", "alcohol withdrawal"],
    "generic_variations": ["Oxazepam base"],
    "common_misspellings": ["Oxazapam", "Oxazepem", "Serex"],
    "safer_alternatives": ["SSRIs for anxiety", "Buspirone", "CBT therapy"],
    "cheaper_alternatives": ["Diazepam"],
    "notes": "Short-to-intermediate acting benzodiazepine. Safer in hepatic impairment because it doesn't require hepatic metabolism (undergoes glucuronidation only). Often used for alcohol withdrawal and anxiety in patients with liver disease. Lower abuse potential than other benzos.",
    "is_active": true
  },
  {
    "generic_name": "Nitrazepam",
    "brand_names": ["Mogadon", "Alodorm", "Nitrados"],
    "active_ingredients": "Nitrazepam 5mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-7834",
    "nafdac_schedule": "schedule_3",
    "nafdac_schedule_date": "2008-01-01",
    "us_dea_schedule": "Schedule IV",
    "uk_controlled_drug_class": "Class C",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 14,
    "requires_photo_id": false,
    "therapeutic_class": "Benzodiazepine",
    "pharmacological_class": "Hypnotic/Anticonvulsant",
    "mechanism_of_action": "GABA-A receptor positive modulator with strong hypnotic effects",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Sleep quality, Morning sedation/hangover, Dependence signs",
    "monitoring_frequency_days": 14,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "D",
    "breastfeeding_safe": false,
    "major_contraindications": ["Severe respiratory insufficiency", "Sleep apnea", "Myasthenia gravis", "Severe hepatic impairment"],
    "allergy_cross_reactions": ["Other benzodiazepines"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["CNS depressants (enhanced sedation)", "Opioids (respiratory depression)", "Alcohol (severe CNS depression)", "Phenytoin (altered levels)"],
    "food_interactions": "Avoid alcohol",
    "search_keywords": ["nitrazepam", "mogadon", "insomnia", "benzodiazepine", "hypnotic", "sleep medication"],
    "generic_variations": ["Nitrazepam base"],
    "common_misspellings": ["Nitrazapam", "Nitrazepem", "Mogadan"],
    "safer_alternatives": ["Zolpidem", "Zopiclone", "Melatonin", "CBT for insomnia"],
    "cheaper_alternatives": ["Diazepam"],
    "notes": "Long-acting benzodiazepine hypnotic. Popular in UK, Africa, and Asia but not available in US. Long half-life (24-30 hours) causes significant morning hangover and daytime sedation. Used for severe insomnia and infantile spasms. Risk of falls in elderly. Not recommended for long-term use.",
    "is_active": true
  }
]
